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Background
Early stage chronic kidney disease (CKD) is an under
recognised, highly prevalent cardiovascular (CV) risk
factor. Despite a clustering of conventional atherosclero-
tic risk factors, there is a disproportionate rate of sud-
den cardiac death, heart failure and stroke rather than
myocardial infarction. It is hypothesised that non-ather-
osclerotic processes, including left ventricular (LV)
hypertrophy and fibrosis account for most of the excess
CV risk.
Methods
In total, 30 patients (mean age 57 +/- 8 years) with CKD
stage 2-4 (mean GFR 58 ± 22 ml/min/1.73 m2) with no
history of cardiovascular disease (mean BP 129 mmHg ±
13/70 mmHg ± 11) or diabetes were compared with age
and gender matched controls. All subjects underwent
cardiac MRI (1.5T Siemens Avanto) for assessment of
LV volumes, myocardial deformation (SPAMM tagging)
and aortic distensibility. Late gadolinium enhancement
(LE) and T1-mapping using a modified look-locker inver-
sion recovery sequence (MOLLI) before and 15 minutes
post gadolinium (0.1 mmol/Kg) for myocardial extracellu-
lar volume (ECV) were performed. Global ECV was the
average measure from basal and mid short axis slices
excluding LGE indicative of infarcted myocardium.
Results
Global ECV was increased in CKD (0.30 ± 0.05 vs. 0.27 ±
0.03, p < 0.05) with associated reductions in long axis sys-
tolic deformation (strain 14.8% ± 2 vs. 17.1% ± 2, p <
0.05), early relaxation (SR e’ 0.50 ± 0.2 vs. 0.67 ± 0.2, p <
0.05) and MAPSE (13 mm ± 2 vs. 17 mm ± 3, p < 0.05).
Aortic distensibility was reduced in CKD (Table 1).
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Table 1 CMR parameters of structure and function
CKD (n = 30) Controls(n = 30)
LVEDVi (ml/m2) 70 (14) 64 (13)
LVESVi (ml/m2) 21 (7) 19 (7)
LV mass index (g/m2) 63 (14) 58 (13)
LVEF (%) 71 (6) 73 (6)
MAPSE (mm) 13 (2) 17 (3)*
LA volume index (ml/m2) 45 (12) 33 (10)*
Peak longitudinal systolic strain (%) 14.8 (2.0) 17.1 (2.0)*
Peak longitudinal systolic strain rate (s-1) 0.71 (0.35) 0.91 (0.23)
Early longitudinal diastolic strain rate (s-1) 0.50 (0.17) 0.67 (0.24)*
Aortic distensibility (mmHg-1) 2.20 (1.56) 3.7 (1.67)*
Data = mean (SD), *p < 0.05
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There were no differences in LV end-diastolic volumes,
end-systolic volumes, LV mass index or LV EF (Table 1).
Three patients had LGE at the RV insertion points and
four patients had diffuse mid-wall LGE in a non-coronary
artery territory distribution. NT-proBNP was not
increased (median 89 ng/L, IQR 150). ECV did not corre-
late with conventional CV risk factors including systolic
blood pressure, cholesterol or urinary albumin:creatinine
ratio.
Conclusions
Diffuse LV fibrosis is increased in early CKD with asso-
ciated reductions in aortic distensibility and abnormal
regional systolic and diastolic function. An increase in
ECV detected by T1 mapping might be a key intermediate
phenotype and follow-up studies are required to deter-
mine if it is predictive of impaired LV systolic function,
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